Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MK-8353 | 1184173-73-6 | MFCD31657387 | 98.1% | 691.84 | 50 MG
SDP

Catalog No. 5000344121
Encompass_Preferred

MK-8353 (SCH900353) is a potent, selective, and orally available ERK1/2 inhibitor with demonstrated antitumor activity. It functions as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an antineoplastic agent, and an apoptosis inducer.

  • Potent and selective ERK1/2 inhibitor
  • Orally available
  • Exhibits antitumor activity
  • IC50s of 23.0 nM for ERK1 and 8.8 nM for ERK2
  • Functions as a mitogen-activated protein kinase inhibitor
  • Acts as an antineoplastic agent
  • Induces apoptosis

Catalog No. 50-003-44121 Supplier Medchemexpress LLC Supplier No. HY11140750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MK-8353 (SCH900353) is a potent, selective, and orally available ERK1/2 inhibitor with demonstrated antitumor activity. It functions as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an antineoplastic agent, and an apoptosis inducer.

  • Potent and selective ERK1/2 inhibitor
  • Orally available
  • Exhibits antitumor activity
  • IC50s of 23.0 nM for ERK1 and 8.8 nM for ERK2
  • Functions as a mitogen-activated protein kinase inhibitor
  • Acts as an antineoplastic agent
  • Induces apoptosis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.